The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Polymyositis and Rhabdomyolysis as Paraneoplastic Manifestations of Primary Liver Cancer

원발성 간암의 신생물딸림증후군으로 표현된 다발성근염과 횡문근융해

  • Seo, Yoon-Jong (Department of Internal Medicine, Sahmyook Medical Center) ;
  • Jang, Jae-Hee (Department of Internal Medicine, Sahmyook Medical Center) ;
  • Park, Ja-Be (Department of Internal Medicine, Sahmyook Medical Center) ;
  • Joo, Jung-Chul (Department of Internal Medicine, Sahmyook Medical Center) ;
  • Jung, Jei-Il (Department of Internal Medicine, Sahmyook Medical Center) ;
  • Jo, Hye-Jae (Department of Pathology, Sahmyook Medical Center) ;
  • Kwak, Jae-Gyu (Department of Neurology, Sahmyook Medical Center)
  • Published : 2012.02.01
⟨ Previous Next ⟩

Abstract

Polymyositis is characterized by symmetrical proximal muscle weakness, nonsuppurative inflammation of skeletal muscle, elevation of muscle enzyme levels, and abnormality of electromyographical change. Its pathogenesis is unclear. Paraneoplastic syndromes are caused by malignant tumors, although not through direct effects of the primary tumor or its metastases. Several paraneoplastic syndromes, including erythrocytosis, hypoglycemia, and hypercholesterolemia, have been reported in patients with hepatocellular carcinoma. A few cases of polymyositis associated with hepatocellular carcinoma and one case of combined hepatocellular-cholangiocarcinoma associated with polymyositis and chronic hepatitis B virus infection have been reported. Skeletal muscle injuries without trauma, including metabolic myopathy, effects of certain drugs and toxins, infection, electrolyte imbalances, and endocrine disorders, may cause rhabdomyolysis. We present here a case of primary liver cancer associated with polymyositis and rhabdomyolysis.

다발성근염은 사지 근위부의 골격근을 대칭적으로 침범하는 원인불명의 자가면역 질환으로, 악성종양과 동반된 사례가 보고되고 있으나 피부 근염에 비해 드물다. 이에 혼합 간세포-담관상피암종으로 추정되는 원발성 간암의 신생물딸림증후군에 의한 횡문근융해와 다발성근염 1예를 경험하여 보고하는 바이다.

Keywords

References

  1. Jeong HJ, Moon WS, Kim SH, et al. A case of combined hepatocellular-chloangiocarcinoma associated with polymyositis and chronic hepatitis B virus infection. Korean J Med 2007;72:79-84.
  2. Stertz G. Polymyositis. Berl Klin Wochenschr 1916;53:489.
  3. Callen JP, Hyla JF, Bole GG Jr, Kay DR. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol 1980;116:295-298. https://doi.org/10.1001/archderm.1980.01640270055013
  4. Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17.
  5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347. https://doi.org/10.1056/NEJM197502132920706
  6. Bezechy R. Dermatomyositis. 1st ed. New York: McGraw-Hill, 1986.
  7. Dawkins RL, Mastaglia FL. Cell-mediated cytotoxicity to muscle in polymyositis: effect of immunosuppression. N Engl J Med 1973;288:434-438. https://doi.org/10.1056/NEJM197303012880903
  8. Grace JT Jr, DAO TL. Dermatomyositis in cancer: a possible etiological mechanism. Cancer 1959;12:648-650. https://doi.org/10.1002/1097-0142(195907/08)12:4<648::AID-CNCR2820120404>3.0.CO;2-0
  9. Alexander S, Forman L. Dermatomyositis and carcinoma: a case report and immunological investigation. Br J Dermatol 1968;80:86-89. https://doi.org/10.1111/j.1365-2133.1968.tb12266.x
  10. Hasegawa K, Uesugi H, Kubota K, et al. Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogastroenterology 2000;47:1425-1427.
  11. Kim PH, Lee HK, Choi DS, et al. Three cases of polymyositis developed associated with chronic liver disease. Korean J Med 1999;56:418-426.
  12. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992;326:363-367. https://doi.org/10.1056/NEJM199202063260602
  13. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41-45. https://doi.org/10.1054/bjoc.2001.1699
  14. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100. https://doi.org/10.1016/S0140-6736(00)03540-6
  15. Lee HY, Kim ND, Sin GC, Kim WC, Kim SJ, Kim TS. A case dermatomyositis associated with adenocarcinoma of stomach. Korean J Med 1986;31:708-714.
  16. Yong SJ, Sin GC, Kim WC, Jeong SH. A case of polymyositis associated with epidermoid carcinoma of lung. Korean J Med 1987;32:678-684.
  17. Joffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993;94:379-387. https://doi.org/10.1016/0002-9343(93)90148-I
  18. Moriguchi M, Suzuki T, Tateishi M, Hara M, Kashiwazaki S. Intravenous immunoglobulin therapy for refractory myositis. Intern Med 1996;35:663-667. https://doi.org/10.2169/internalmedicine.35.663
  19. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. report 7th. Acta Heparol Jpn 1986;27: 1161-1169. https://doi.org/10.2957/kanzo.27.1161